China · Series B startup

Who invested in GeneQuantum Healthcare

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2019, from 1 source

Latest round
Series B, $15MMay 2019
Led by
Huagai Capital
Investors
5 (1 led)
See who backed them

The rounds

  1. May 2019
    Series B$15M

    Reported by Prnewswire

Everyone who backed them

Huagai CapitalPrivate equity1round, led 1
TF CapitalVC firm1round
Changjinboyano record of our own yet1round
Hofonno record of our own yet1round
Oriza Seedno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about GeneQuantum Healthcare

Who invested in GeneQuantum Healthcare?

GeneQuantum Healthcare's investors include Huagai Capital, TF Capital, Changjinboya, Hofon and Oriza Seed. Huagai Capital led its latest round.

How much has GeneQuantum Healthcare raised?

GeneQuantum Healthcare has raised $15M across 1 round since 2019.

When did GeneQuantum Healthcare last raise?

GeneQuantum Healthcare's most recent round was a Series B of $15M in May 2019, led by Huagai Capital.

What was GeneQuantum Healthcare's biggest round?

Its most recent round, $15M in May 2019, is also its largest on record.

Who backed GeneQuantum Healthcare first?

GeneQuantum Healthcare's first round on record, in May 2019, was backed by Huagai Capital, TF Capital and Changjinboya and 2 others.

What stage is GeneQuantum Healthcare at?

GeneQuantum Healthcare's latest named round is a Series B, in May 2019.

Where is GeneQuantum Healthcare based?

GeneQuantum Healthcare is based in China.

Who led GeneQuantum Healthcare's rounds?

Huagai Capital led the Series B in 2019.

Companies like GeneQuantum Healthcare

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.